123 related articles for article (PubMed ID: 30526836)
41. Acute megakaryoblastic leukemia with a four-way variant translocation originating the RBM15-MKL1 fusion gene.
Torres L; Lisboa S; Vieira J; Cerveira N; Santos J; Pinheiro M; Correia C; Bizarro S; Almeida M; Teixeira MR
Pediatr Blood Cancer; 2011 May; 56(5):846-9. PubMed ID: 21370421
[TBL] [Abstract][Full Text] [Related]
42. Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.
de Rooij JD; Masetti R; van den Heuvel-Eibrink MM; Cayuela JM; Trka J; Reinhardt D; Rasche M; Sonneveld E; Alonzo TA; Fornerod M; Zimmermann M; Pigazzi M; Pieters R; Meshinchi S; Zwaan CM; Locatelli F
Blood; 2016 Jun; 127(26):3424-30. PubMed ID: 27114462
[TBL] [Abstract][Full Text] [Related]
43. MLL-MLLT10 fusion gene in pediatric acute megakaryoblastic leukemia.
Morerio C; Rapella A; Tassano E; Rosanda C; Panarello C
Leuk Res; 2005 Oct; 29(10):1223-6. PubMed ID: 16111539
[TBL] [Abstract][Full Text] [Related]
44. A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia.
Gu TL; Mercher T; Tyner JW; Goss VL; Walters DK; Cornejo MG; Reeves C; Popova L; Lee K; Heinrich MC; Rush J; Daibata M; Miyoshi I; Gilliland DG; Druker BJ; Polakiewicz RD
Blood; 2007 Jul; 110(1):323-33. PubMed ID: 17360941
[TBL] [Abstract][Full Text] [Related]
45. Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases.
Ribeiro RC; Oliveira MS; Fairclough D; Hurwitz C; Mirro J; Behm FG; Head D; Silva ML; Raimondi SC; Crist WM
Leuk Lymphoma; 1993 Jul; 10(4-5):299-306. PubMed ID: 8220128
[TBL] [Abstract][Full Text] [Related]
46. MN1-Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cells.
Wenge DV; Felipe-Fumero E; Angenendt L; Schliemann C; Schmidt E; Schmidt LH; Thiede C; Ehninger G; Berdel WE; Arteaga MF; Mikesch JH
Oncogenesis; 2015 Dec; 4(12):e179. PubMed ID: 26690545
[TBL] [Abstract][Full Text] [Related]
47. Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial.
Teyssier AC; Lapillonne H; Pasquet M; Ballerini P; Baruchel A; Ducassou S; Fenneteau O; Petit A; Cuccuini W; Ragu C; Preudhomme C; Mercher T; Sirvent N; Leverger G
Pediatr Hematol Oncol; 2017 Nov; 34(8):425-427. PubMed ID: 29303660
[TBL] [Abstract][Full Text] [Related]
48. Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome.
Lightfoot J; Hitzler JK; Zipursky A; Albert M; Macgregor PF
Leukemia; 2004 Oct; 18(10):1617-23. PubMed ID: 15343346
[TBL] [Abstract][Full Text] [Related]
49. Molecular lesions in childhood and adult acute megakaryoblastic leukaemia.
Hama A; Muramatsu H; Makishima H; Sugimoto Y; Szpurka H; Jasek M; O'Keefe C; Takahashi Y; Sakaguchi H; Doisaki S; Shimada A; Watanabe N; Kato K; Kiyoi H; Naoe T; Kojima S; Maciejewski JP
Br J Haematol; 2012 Feb; 156(3):316-25. PubMed ID: 22122069
[TBL] [Abstract][Full Text] [Related]
50. Skeletal manifestations of pediatric acute megakaryoblastic leukemia.
Athale UH; Kaste SC; Razzouk BI; Rubnitz JE; Ribeiro RC
J Pediatr Hematol Oncol; 2002 Oct; 24(7):561-5. PubMed ID: 12368696
[TBL] [Abstract][Full Text] [Related]
51. Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
Roy A; Roberts I; Norton A; Vyas P
Br J Haematol; 2009 Oct; 147(1):3-12. PubMed ID: 19594743
[TBL] [Abstract][Full Text] [Related]
52. A pediatric case of acute megakaryocytic leukemia with double chimeric transcripts of CBFA2T3-GLIS2 and DHH-RHEBL1.
Mitsui-Sekinaka K; Sekinaka Y; Ogura Y; Honda M; Ohyama R; Oyama C; Isobe K; Mori M; Arakawa Y; Koh K; Hanada R; Nonoyama S; Kawaguchi H
Leuk Lymphoma; 2018 Jun; 59(6):1511-1513. PubMed ID: 29043865
[No Abstract] [Full Text] [Related]
53. CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target.
Le Q; Hadland B; Smith JL; Leonti A; Huang BJ; Ries R; Hylkema TA; Castro S; Tang TT; McKay CN; Perkins L; Pardo L; Sarthy J; Beckman AK; Williams R; Idemmili R; Furlan S; Ishida T; Call L; Srivastava S; Loeb AM; Milano F; Imren S; Morris SM; Pakiam F; Olson JM; Loken MR; Brodersen L; Riddell SR; Tarlock K; Bernstein ID; Loeb KR; Meshinchi S
J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36136600
[TBL] [Abstract][Full Text] [Related]
54. Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution.
Su N; Li Z; Yang J; Fu Y; Zhu X; Miao H; Yu Y; Jiang W; Le J; Qian X; Wang H; Qian M; Zhai X
Front Oncol; 2022; 12():915833. PubMed ID: 36003795
[TBL] [Abstract][Full Text] [Related]
55. Transcription factor GATA-1 and Down syndrome leukemogenesis.
Muntean AG; Ge Y; Taub JW; Crispino JD
Leuk Lymphoma; 2006 Jun; 47(6):986-97. PubMed ID: 16840187
[TBL] [Abstract][Full Text] [Related]
56. Acute megakaryoblastic leukemia with t(17;22)(q21;q13) and liver dysfunction.
Chitlur MB; Bhambhani K; Mohamed AN; Ravindranath Y; Savaşan S
Cancer Genet Cytogenet; 2004 Oct; 154(2):167-8. PubMed ID: 15474155
[TBL] [Abstract][Full Text] [Related]
57. GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.
Ariffin H; Garcia JC; Daud SS; Ibrahim K; Aizah N; Ong GB; Chong LA; Mohamad Z
Pediatr Blood Cancer; 2009 Jul; 53(1):108-11. PubMed ID: 19260099
[TBL] [Abstract][Full Text] [Related]
58.
de Matos RRC; Ferreira GM; Bonecker S; Rouxinol M; da Costa ES; Mello FV; Abdelhay E; Ribeiro RC; Zalcberg I; Silva MLM
Leuk Lymphoma; 2023 Dec; 64(12):2042-2046. PubMed ID: 37548333
[No Abstract] [Full Text] [Related]
59. LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia.
Emmrich S; Streltsov A; Schmidt F; Thangapandi VR; Reinhardt D; Klusmann JH
Mol Cancer; 2014 Jul; 13():171. PubMed ID: 25027842
[TBL] [Abstract][Full Text] [Related]
60. Mutational analysis of candidate tumor-associated genes in acute megakaryoblastic leukemia.
Bhat R; Malinge S; Gamis AS; Sorrell AD; Hilden JM; Ketterling RP; Paietta E; Tallman MS; Crispino JD
Leukemia; 2009 Nov; 23(11):2159-60. PubMed ID: 19657363
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]